Skip to content
Screener

USANA Health Sciences USNA Q4 2025 Annual earnings

Reported February 17, 2026 · After market close

Revenue$226.2MBeat by $241.0K
EPS$0.60Beat by $0.19
Revenue estimate$226.0M
EPS estimate$0.41

Next report

Oct 28, 2026 (in 3 months)
Revenue estimate$224.7M
EPS estimate$0.43

Financials

Q4 2025

Income statement

See full
Revenue$226.2M+5.9%
Gross profit$176.8M+1.0%
Operating income$3.8M-53.5%

Balance sheet

See full
Cash & equivalents$158.4M-12.9%
Total debt$18.0M+10.8%
Total equity$533.1M+0.2%
Total assets$742.9M-0.7%

Cash flow

See full
CapEx$2.8M+55.1%

Valuation & ratios

Valuation

as of 01/03/26
See full
Market cap$396.69M-36.1%
Enterprise value$256.27M-43.7%
P/S0.4×-0.3×

Profitability

See full
Gross margin78.3%-2.8pp
Operating margin4%-3.7pp

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio2.2×+0.2×

Segments

By geography

See full
Greater China$100.1M-11.1%
Americas and Europe$75.1M+61.8%
Southeast Asia Pacific$34.2M-10.1%
North Asia$16.8M+1.7%

By segment

See full
Hiya$30.1M+6,013%

FAQ

When did USANA Health Sciences report Q4 2025 earnings?
USANA Health Sciences (USNA) reported Q4 2025 earnings on February 17, 2026 after market close.
What were USANA Health Sciences's Q4 2025 revenue and EPS?
USANA Health Sciences reported revenue of $226.2M and eps of $0.60 for Q4 2025.
Did USANA Health Sciences beat estimates in Q4 2025?
Revenue beat the consensus estimate of $226.0M by $241.0K. EPS beat the consensus estimate of $0.41 by $0.19.
How did USANA Health Sciences's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.9% from $213.6M a year earlier and eps declined 6.3% from $0.64.
Where can I find USANA Health Sciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000896264-26-000014) and the 10-K periodic report (0000896264-26-000021) directly on SEC EDGAR. The filing index links above go to sec.gov.